AliveCor QT Service vs CardioLogs ECG Analysis Platform

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by AliveCor
VS
by CardioLogs (acquired by Philips in 2021)

AI Verdict

AliveCor QT Service is specialized for precise QT and QTc interval measurements, crucial for cardiac safety and medication management. In contrast, the Cardiologs ECG Analysis Platform offers a broader AI-powered solution for detecting various arrhythmias across a wider range of cardiac monitoring devices. Therefore, AliveCor is ideal for specific drug-related cardiac risk assessment, while Cardiologs suits general arrhythmia diagnosis from diverse sources.

Choose AliveCor QT Service if…

Choose AliveCor QT Service if your primary need is instant and highly accurate QT and QTc interval measurements to assess cardiac safety, especially when prescribing medications with known QT prolongation risks. This tool is specifically designed for use with AliveCor 6-Lead ECGs, providing immediate insights for critical clinical decision-making regarding drug-induced cardiac events.

View AliveCor QT Service →

Choose CardioLogs ECG Analysis Platform if…

Choose Cardiologs ECG Analysis Platform if you require a comprehensive, AI-powered solution for broad arrhythmia detection and diagnosis across a diverse range of ECG monitoring devices. This platform is ideal for practices needing efficient analysis of data from Holter monitors, smartwatches, and ECG patches, offering automated detection of various arrhythmias and customizable reports to streamline diagnostic workflows.

View CardioLogs ECG Analysis Platform →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AliveCor QT Service CardioLogs ECG Analysis Platform
Pricing Varies by product and service, with subscription options available. Unknown
Deployment Mobile app, cloud-based platform, EHR integration. Cloud-based
BAA Available Yes AI-estimated Unknown
FDA Status 1 AI-estimated 1 AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform is consistently described as having a 'nice user interface' and 'user friendly interface', offering customizable reports and multi-device compatibility that streamline workflows. While AliveCor QT Service integrates with apps and portals, some user feedback indicates interface challenges, despite recent improvements.

Clinical Value

Tie

Both tools offer substantial clinical value in distinct areas. AliveCor QT Service provides instant, accurate QT/QTc measurements critical for cardiac safety and medication management, backed by clinical studies. CardioLogs ECG Analysis Platform delivers rapid and accurate arrhythmia detection across multiple devices, demonstrating high sensitivity and reduced false positives in clinical validation.

Pricing & Value

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform offers more pricing transparency by explicitly stating a 'pay per ECG regardless of the number of users' model, allowing for clearer cost estimation. AliveCor QT Service, in contrast, only states 'contact vendor for pricing details,' providing less insight into its cost structure.

Enterprise Readiness

CardioLogs ECG Analysis Platform

Both tools are FDA cleared, HIPAA compliant, and offer EHR integration. However, CardioLogs ECG Analysis Platform's explicit ISO/IEC 27001 certification for secure hosting and its integration into Philips as a solution demonstrate a higher level of robust enterprise-grade security and corporate backing.

Innovation

Tie

Both tools showcase significant innovation through their application of AI and deep neural networks. AliveCor QT Service's 'InstantQT' for real-time, precise cardiac safety assessment is a highly impactful, specialized innovation. CardioLogs ECG Analysis Platform, as the first FDA-cleared AI solution for ECG analysis, demonstrates broader innovative impact with its multi-device compatibility and superior arrhythmia detection.

Support & Docs

CardioLogs ECG Analysis Platform

CardioLogs ECG Analysis Platform explicitly offers '24/7 Customer Support' and 'Training And Onboarding,' alongside a dedicated support center and product manuals. AliveCor QT Service provides customer support via phone and email and has user guides in its portal, but does not specify 24/7 availability or explicit onboarding programs.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AliveCor QT Service CardioLogs ECG Analysis Platform
Tool Name AliveCor QT Service CardioLogs ECG Analysis Platform
Company AliveCor Cardiologs Technologies (now part of Philips)
Primary Function/Key Analysis Provides instant, accurate QT and QTc interval measurements for cardiac safety assessment and medication prescribing decisions. Rapid, accurate, and efficient analysis of ECG data for arrhythmia detection and diagnosis.
ECG Source Compatibility Analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices (e.g., KardiaMobile 6L). Multi-Device Compatibility (Holter, smartwatches, ECG patches).
AI Technology Utilizes AI and deep neural networks for ECG analysis. AI-Powered ECG Analysis (Deep Neural Networks).

Videos

Demos, reviews, and walkthroughs featuring AliveCor QT Service and CardioLogs ECG Analysis Platform.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AliveCor QT Service is a cloud-based Software as a Medical Device (SaMD) focused on providing instant, accurate QT and QTc interval measurements from AliveCor 6-Lead ECGs to assess cardiac safety and inform medication prescribing decisions. CardioLogs ECG Analysis Platform, now a Philips solution, uses medical-grade AI and cloud technology for rapid, accurate, and efficient analysis of ECG data from various cardiac monitoring devices, primarily aiding physicians in arrhythmia detection and diagnosis.
AliveCor QT Service specifically analyzes ECGs from AliveCor 6-Lead ambulatory ECG devices, such as the KardiaMobile 6L. CardioLogs ECG Analysis Platform offers multi-device compatibility, capable of analyzing ECG data from various cardiac monitoring devices including Holter monitors, smartwatches, and ECG patches.
AliveCor QT Service provides instant QT and QTc interval measurements, utilizing Bazett's and Fridericia's formulas, as InstantQT. CardioLogs ECG Analysis Platform offers automated arrhythmia detection for conditions such as AFib and VT, and generates customizable reports.
For AliveCor QT Service, physicians need to contact the vendor directly for pricing details. CardioLogs ECG Analysis Platform operates on a 'pay per ECG' model, regardless of the number of users, and requires contacting sales for a customized quote.
AliveCor QT Service integrates with the KardiaStation app and KardiaPro portal, and offers an API for integration with EHR, SDK, CRM, EDC, and PSP platforms. CardioLogs ECG Analysis Platform provides integration with EHR Systems.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.